(Q38864921)

English

Organized metabolic crime in prostate cancer: The coexpression of MCT1 in tumor and MCT4 in stroma is an independent prognosticator for biochemical failure

scientific article published on 8 June 2015

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Organized metabolic crime in prostate cancer: The coexpression of MCT1 in tumor and MCT4 in stroma is an independent prognosticator for biochemical failure (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Sigve Andersen

1

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Ørjan Solstad

2

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Line Moi

3

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Tom Donnem

4

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Marte Eilertsen

5

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Yngve Nordby

6

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Nora Ness

7

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Elin Richardsen

8

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Lill-Tove Busund

9

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Roy M Bremnes

10

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

publication date

8 June 2015

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Urologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

338.e9-17

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Defining the threshold for significant versus insignificant prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.013

7 January 2021

Cancer statistics, 2014

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.013

7 January 2021

Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.013

7 January 2021

Microenvironmental regulation of tumor progression and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.013

7 January 2021

Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.013

7 January 2021

Hallmarks of Cancer: The Next Generation

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.013

7 January 2021

On the Origin of Cancer Cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.013

7 January 2021

Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.013

7 January 2021

Lactate transporters in the context of prostate cancer metabolism: what do we know?

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.013

7 January 2021

Targeting the lactate transporter MCT1 in endothelial cells inhibits lactate-induced HIF-1 activation and tumor angiogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.013

7 January 2021

Carbohydrate restriction and lactate transporter inhibition in a mouse xenograft model of human prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.013

7 January 2021

Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.013

7 January 2021

A lactate shuttle system between tumour and stromal cells is associated with poor prognosis in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.013

7 January 2021

Monocarboxylate transporters 1-4 in NSCLC: MCT1 is an independent prognostic marker for survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.013

7 January 2021

Disease-specific outcomes of radical prostatectomies in Northern Norway; a case for the impact of perineural infiltration and postoperative PSA-doubling time

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.013

7 January 2021

The metabolic interactions between tumor cells and tumor-associated stroma (TAS) in prostatic cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.013

7 January 2021

The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.013

7 January 2021

Evidence supporting the existence of an activity-dependent astrocyte-neuron lactate shuttle

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.013

7 January 2021

Oxidative metabolism of pyruvate is required for meiotic maturation of murine oocytes in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.013

7 January 2021

Blood flow and oxygenation status of prostate cancers

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.013

7 January 2021

Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: A new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.013

7 January 2021

Comparison of hypoxia transcriptome in vitro with in vivo gene expression in human bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.013

7 January 2021

Role of monocarboxylate transporters in human cancers: state of the art.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.013

7 January 2021

Effect of mitochondrial metabolism-interfering agents on cancer cell mitochondrial function and radio/chemosensitivity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.013

7 January 2021

Metabolomics approaches and applications in prostate cancer research

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.013

7 January 2021

Cancer metabolism: new validated targets for drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.013

7 January 2021

Targeting cancer metabolism

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.013

7 January 2021

Carbohydrate intake, glycemic index and prostate cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.013

7 January 2021

Nutrition and prostate cancer: an overview

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.013

7 January 2021

The effect of carbohydrate restriction on prostate cancer tumor growth in a castrate mouse xenograft model

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.013

7 January 2021

Low-carbohydrate diets and prostate cancer: how low is "low enough"?

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.013

7 January 2021

Physical activity and urologic cancers

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.013

7 January 2021

Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.013

7 January 2021

Identifiers

10.1016/J.UROLONC.2015.05.013

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38864921&oldid=1966871949"